Reconstituted high density lipoprotein(rHDL)carriers for cardiovascular drugs delivery

来源 :2016年中国药物制剂大会、中国药学会药剂专业委员会2016年学术年会、中国化学制药工业协会固体制剂专业委员会2016年 | 被引量 : 0次 | 上传用户:hualing_xue
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  High-density lipoprotein(HDL),a heterogeneous class of plasma lipoproteins,is a dynamic serum protectant against the development of atherosclerosis and the resultant illnesses such as heart disease and stroke1.In the past decades,various research groups have been successful in development of recombinant HDL(rHDL),with physicochemical properties similar to those of native HDL.
其他文献
会议
会议
会议
As a novel surfactant,bolaamphiphile molecule consisting of two functional hydrophilic polar head groups connected via single or multiple hydrophobic alkyl chains is different from the conventional si
会议
Polymeric micelles(PMs)have been widely proven to enhance the oral bioavailibility of poorly water-soluble drugs.However,their in vivo fate and absorption mechanism have not been elucidated clearly ye
会议
Thymidine kinases(TKs)have been considered as one of the potential targets for anticancer therapeutic due to its abnormally high level of expression in cancer tissue.
会议
会议
Lipid-polymer hybrid nanoparticles with unique hybrid architecture have been widely applied on nanomedicine.Phospholipids are molecules with hydrophilic head group and hydrophobic acyl chains(Fig.1A).
Recently,conjugation of antitumor drug with functional peptide such as cell penetrating peptide(CCP)has been proved to be an efficient method to conquer the drug resistance of cancer and improve the d
会议